Trinity Biotech (TRIB) Free Cash Flow Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) Free Cash Flow Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 9.23% |
| 10 | Trinity Biotech | 6.82 Mn | 1.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.84% |
| Jun 30, 2021 | -93.93% |
| Dec 31, 2016 | 1.93% |
| Dec 31, 2015 | -4.94% |
| Dec 31, 2014 | -11.36% |
| Dec 31, 2013 | 2.46% |
| Dec 31, 2012 | 13.09% |